PRESS RELEASE

Q2 2020 — Press release

Q2 2020PDF · 23 pages155 KB
July 28, 2020
3M Reports Second-Quarter 2020 Results
Strong Execution and Cash Flow in Uncertain Environment
Second-Quarter Highlights:
Sales of $7.2 billion, down 12.2 percent year-on-year
Organic local-currency sales declined 13.1 percent year-on-year
GAAP EPS of $2.22; adjusted EPS of $1.78
Both GAAP and adjusted EPS affected by COVID-19 impacts and actions
(including associated restructuring charge of $58 million, or $0.08 per share)
Operating cash flow of $1.9 billion, up 15 percent year-on-year; adjusted free
cash flow of $1.5 billion, up 18 percent year-on-year
Improving sales trends; July month-to-date sales up low-single digits year-on-
year
Guidance remains withdrawn, company to continue to provide monthly sales
updates
ST. PAUL, Minn.--(BUSINESS WIRE)-- 3M (NYSE: MMM) today reported second-quarter
2020 results.
“While our results were significantly impacted by the global economic slowdown, we
executed well, managed our costs and delivered another quarter of robust cash flow,” said
Mike Roman, 3M chairman and chief executive officer. “We are taking actions to navigate
near-term challenges, while relentlessly innovating for our customers and investing for the
future to lead out of the slowdown and continue to deliver long-term value for our
shareholders.
“Globally across 3M, we continue to fight the pandemic from all angles and help ensure the
safety of our employees, healthcare workers and first-responders, and the public,” Roman
continued. “I remain incredibly proud of how our team is leading through these
unprecedented times, and I thank all 3Mers for their tireless efforts.”
Advancing Pandemic Response in Dynamic Environment
3M has been aggressively responding to the COVID-19 pandemic given its critical role as a
provider of personal protective equipment in the U.S. and across the world. The company
continues to adjust and adapt quickly with a focus on mitigating the near-term impact while
positioning 3M’s businesses for success coming out of the crisis. The company continues to:
Protect employees
Strong, global workplace safety protocols to protect employees
Employees effectively adjusting to different ways to work while ensuring business
continuity
In early stages of return-to-workplace; complying with government guidelines and
policies

-- 1 of 23 --

Lead in pandemic response
Global production of nearly 800 million respirators in the first half of 2020;
approximately 50 percent distributed in U.S. primarily to healthcare and FEMA;
on-track to approximately 2 billion globally, including 1 billion in the U.S. for full-
year 2020
Partnering with U.S. Department of Defense and other governments to expand
global respirator manufacturing capacity
Advanced membrane technology being used in blood oxygenation procedures;
biopharma filtration solutions supporting new vaccine and therapeutic
development efforts
Expanding partnerships, including new innovative rapid diagnostic COVID-19 test
with the Massachusetts Institute of Technology
Fight fraud and price gouging
Created hotlines and websites around the world to report suspected fraud
Filed 18 lawsuits including in 10 U.S. states and Canada
Secured removal of more than 7,000 counterfeit websites and more than 10,000
false or deceptive social media posts to date
Relentlessly serve customers
Maintaining strong customer service with new global enterprise operations team
Ongoing adjustments to manufacturing/supply chain operations as demand
trends evolve
Nearly all plants and distribution centers fully or partially operational
Continue to innovate for customers to solve big challenges such as air quality,
automotive electrification and food safety; Priority Growth Platforms
outperforming markets they serve
Protect financial flexibility
Strong operating cash flow of $1.9 billion, up 15 percent year-on-year; adjusted
free cash flow of $1.5 billion, up 18 percent year-on-year, benefitting from year-
on-year improvements in working capital and timing of income tax payments
Aggressively reduced costs by approximately $400 million year-on-year to help
offset COVID-19 related impacts and actions
Undertook restructuring actions as a result of the COVID-19 pandemic and
related economic impact resulting in a $58 million charge
Divested the drug delivery business, generating a pre-tax gain of $387 million
Strengthened the balance sheet by reducing net debt by $1.7 billion since March
31, 2020
Second-Quarter Results
The COVID-19 pandemic continues to evolve and affect 3M’s businesses in a number of
ways. During the second quarter, end-market demand remained strong in personal safety,
home improvement, general cleaning, semiconductor, data center and biopharma filtration.
At the same time, several other end markets continued to experience significant weakness
including healthcare elective procedures, automotive OEM and aftermarket, general
industrial, commercial solutions and office supplies.
Second-quarter sales declined 12.2 percent year-on-year to $7.2 billion. Organic local-
currency sales declined 13.1 percent, while acquisitions, net of divestitures, increased sales
by 2.4 percent. Foreign currency translation reduced sales by 1.5 percent year-on-year.

-- 2 of 23 --

Total sales declined 0.4 percent in Health Care, 6.2 percent in Consumer, 9.2 percent in
Safety and Industrial and 20.9 percent in Transportation and Electronics. Organic local-
currency sales decreased 5.0 percent in Consumer, 6.1 percent in Safety and Industrial,
12.4 percent in Health Care and 18.9 percent in Transportation and Electronics.
On a geographic basis, total sales declined 8.5 percent in Asia Pacific, 12.7 percent in the
Americas and 16.4 percent in EMEA (Europe, Middle East and Africa). Organic local-
currency sales decreased 8.1 percent in Asia Pacific, 14.5 percent in EMEA and 15.6
percent in the Americas.
Second-quarter GAAP earnings were $2.22 per share, an increase of 15.6 percent year-on-
year, with operating income of $1.7 billion and operating margins of 24.3 percent.
Excluding special items, second-quarter adjusted earnings were $1.78 per share, a decline
of 16.4 percent year-on-year, with operating income of $1.4 billion and operating margins of
19.6 percent, as referenced in the “Supplemental Financial Information Non-GAAP
Measures” section.
The company’s operating cash flow was $1.9 billion with adjusted free cash flow of $1.5
billion contributing to adjusted free cash flow conversion of 149 percent. See the
“Supplemental Financial Information Non-GAAP Measures” section for applicable
information.
The company paid $846 million in cash dividends to shareholders during the quarter.
Second-Quarter Business Group Discussion
Safety and Industrial
Sales of $2.7 billion, down 9.2 percent in U.S. dollars. Organic local-currency sales
decreased 6.1 percent, foreign currency translation decreased sales by 2.2 percent,
and divestitures decreased sales by 0.9 percent.
On an organic local-currency basis:
Sales increased in personal safety; sales declined in closure and masking,
electrical markets, roofing granules, industrial adhesives and tapes, abrasives,
and automotive aftermarket.
Sales declined in EMEA, Asia Pacific and the Americas.
Segment operating income was $636 million, a decline of 1.6 percent year-on-year;
operating margins of 23.8 percent.
Transportation and Electronics
Sales of $1.9 billion, down 20.9 percent in U.S. dollars. Organic local-currency sales
decreased 18.9 percent, foreign currency translation decreased sales by 0.9 percent,
and divestitures decreased sales by 1.1 percent.
On an organic local-currency basis:
Sales decreased in electronics, transportation safety, advanced materials,
commercial solutions, and automotive and aerospace.
Sales declined in Asia Pacific, the Americas and EMEA.
Segment operating income was $382 million, a decline of 35.4 percent year-on-year;

-- 3 of 23 --

operating margins of 19.7 percent.
Health Care
Sales of $1.8 billion, down 0.4 percent in U.S. dollars. Organic local-currency sales
decreased 12.4 percent, foreign currency translation decreased sales by 1.6 percent
and acquisitions, net of divestitures, increased sales by 13.6 percent.
On an organic local-currency basis:
Sales grew in separation and purification; sales declined in medical solutions,
food safety, health information systems and oral care.
Sales declined in EMEA, Asia Pacific and the Americas.
Segment operating income was $306 million, a decline of 36.7 percent year-on-year;
operating margins of 16.8 percent.
Consumer
Sales of $1.2 billion, down 6.2 percent in U.S. dollars. Organic local-currency sales
decreased 5.0 percent and foreign currency translation decreased sales by 1.2
percent.
On an organic local-currency basis:
Sales grew in home care, and home improvement; sales declined in consumer
health care, and stationery and office supplies.
Sales declined in the Americas, Asia Pacific and EMEA.
Segment operating income was $287 million, up 4.8 percent year-on-year; operating
margins of 23.2 percent.
Guidance Remains Withdrawn; July 2020 Sales Trends
Due to the continued evolving and uncertain impact of the COVID-19 pandemic, 3M is not
able to estimate the full duration, magnitude and pace of recovery across its diverse end
markets with reasonable accuracy. Therefore, 3M continues to believe it is prudent to not
provide guidance. The company is seeing broad-based sales improvements across
businesses and geographies to start the third quarter. With one week left in July, total
company sales are currently up low-single digits year-on-year. 3M will maintain its monthly
reporting of sales information during the third-quarter to provide transparency on its ongoing
business performance.
3M will conduct an investor teleconference at 9:00 a.m. EDT (8:00 a.m. CDT) today.
Investors can access this conference via the following:
Live webcast at http://investors.3M.com.
Live telephone:
Call 800-762-2596 within the U.S. or +1 212-231-2916 outside the U.S. Please join the
call at least 10 minutes before the start time.
Webcast replay:
Go to 3M’s Investor Relations website at http://investors.3M.com and click on
“Quarterly Earnings.”
Telephone replay:
Call 800-633-8284 within the U.S. or +1 402-977-9140 outside the U.S. (for both U.S.
and outside the U.S., the access code is 21930638). The telephone replay will be

-- 4 of 23 --

available until 11:30 a.m. EDT (10:30 a.m. CDT) on August 4, 2020.
Forward-Looking Statements
This news release contains forward-looking information about 3M's financial results and
estimates and business prospects that involve substantial risks and uncertainties. You can
identify these statements by the use of words such as "anticipate," "estimate," "expect,"
"aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and
other words and terms of similar meaning in connection with any discussion of future
operating or financial performance or business plans or prospects. Among the factors that
could cause actual results to differ materially are the following: (1) worldwide economic,
political, regulatory, capital markets and other external conditions and other factors beyond
the Company's control, including natural and other disasters or climate change affecting the
operations of the Company or its customers and suppliers; (2) risks related to public health
crises such as the global pandemic associated with the coronavirus (COVID-19); (3)
liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-
related products and chemistries, and claims and governmental regulatory proceedings and
inquiries related to PFAS in a variety of jurisdictions; (4) legal proceedings, including
significant developments that could occur in the legal and regulatory proceedings described
in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2019, and any
subsequent quarterly reports on Form 10-Q (the “Reports”); (5) competitive conditions and
customer preferences; (6) foreign currency exchange rates and fluctuations in those rates;
(7) the timing and market acceptance of new product offerings; (8) the availability and cost of
purchased components, compounds, raw materials and energy (including oil and natural gas
and their derivatives) due to shortages, increased demand or supply interruptions (including
those caused by natural and other disasters and other events); (9) unanticipated problems or
delays with the phased implementation of a global enterprise resource planning (ERP)
system, or security breaches and other disruptions to the Company's information technology
infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures and other
unusual events resulting from portfolio management actions and other evolving business
strategies, and possible organizational restructuring; (11) operational execution, including
scenarios where the Company generates fewer productivity improvements than estimated;
(12) financial market risks that may affect the Company’s funding obligations under defined
benefit pension and postretirement plans; and (13) the Company's credit ratings and its cost
of capital. Changes in such assumptions or factors could produce significantly different
results. A further description of these factors is located in the Reports under "Cautionary
Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items
1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as
updated by applicable Current Reports on Form 8-K. The information contained in this news
release is as of the date indicated. The Company assumes no obligation to update any
forward-looking statements contained in this news release as a result of new information or
future events or developments.
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME
(Millions, except per-share amounts)
(Unaudited)
Three months ended Six months ended

-- 5 of 23 --

June 30, 	June 30,
2020 	2019 	2020 	2019
Net sales 	$ 7,176 	$ 8,171 $15,251 $ 16,034
Operating expenses
Cost of sales 	3,805 	4,313 	7,914 	8,623
Selling, general and administrative
expenses 	1,594 	1,686 	3,362 	3,634
Research, development and related
expenses 	424 	470 	961 	947
Gain on sale of businesses 	(387) 	— 	(389) 	(8)
Total operating expenses 	5,436 	6,469 11,848 	13,196
Operating income 	1,740 	1,702 	3,403 	2,838
Other expense (income), net 	111 	256 	207 	304
Income before income taxes 	1,629 	1,446 	3,196 	2,534
Provision for income taxes 	342 	315 	615 	510
Net income including noncontrolling interest 	$ 1,287 	$ 1,131 $ 2,581 $ 2,024
Less: Net income (loss) attributable to
noncontrolling interest 	(3) 	4 	(1) 	6
Net income attributable to 3M 	$ 1,290 	$ 1,127 $ 2,582 $ 2,018
Weighted average 3M common shares
outstanding – basic 	577.0 	577.7 	576.9 	577.6
Earnings per share attributable to 3M
common shareholders – basic 	$ 2.24 $ 	1.95 $ 4.48 $ 3.49
Weighted average 3M common shares
outstanding – diluted 	580.8 	586.1 	581.2 	587.3
Earnings per share attributable to 3M
common shareholders – diluted 	$ 2.22 $ 	1.92 $ 4.44 $ 3.44
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)

-- 6 of 23 --

June 30, 	December 31,
2020 	2019
ASSETS
Current assets
Cash and cash equivalents 	$ 	4,219 	$ 	2,353
Marketable securities – current 	247 	98
Accounts receivable – net 	4,459 	4,791
Inventories 	4,168 	4,134
Prepaids 	567 	704
Other current assets 	446 	891
Total current assets 	14,106 	12,971
Property, plant and equipment – net 	9,089 	9,333
Operating lease right of use assets 	840 	858
Goodwill and intangible assets – net 	19,393 	19,823
Other assets 	1,651 	1,674
Total assets 	$ 	45,079 	$ 	44,659
LIABILITIES AND EQUITY
Current liabilities
Short-term borrowings and
current portion of long-term debt 	$ 	1,486 	$ 	2,795
Accounts payable 	1,975 	2,228
Accrued payroll 	500 	702
Accrued income taxes 	371 	194
Operating lease liabilities – current 	248 	247
Other current liabilities 	2,702 	3,056
Total current liabilities 	7,282 	9,222
Long-term debt 	19,276 	17,518
Other liabilities 	7,606 	7,793
Total liabilities 	$ 	34,164 	$ 	34,533
Total equity 	$ 	10,915 	$ 	10,126
Shares outstanding
June 30, 2020: 576,019,442 shares
December 31, 2019: 575,184,835 shares
Total liabilities and equity 	$ 	45,079 	$ 	44,659
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)

-- 7 of 23 --

Six months ended
June 30,
2020 	2019
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 	$ 3,118 	$ 2,710
Cash flows from investing activities:
Purchases of property, plant and equipment 	(711) 	(812)
Acquisitions, net of cash acquired 	(25) 	(704)
Purchases and proceeds from sale or maturities of marketable
securities and investments – net 	342 	254
Proceeds from sale of businesses, net of cash sold 	573 	6
Other investing activities 	23 	21
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 	202 	(1,235)
Cash flows from financing activities:
Change in debt 	467 	953
Purchases of treasury stock 	(366) 	(1,101)
Proceeds from issuances of treasury stock pursuant to stock
option and benefit plans 	236 	365
Dividends paid to shareholders 	(1,693) 	(1,660)
Other financing activities 	(45) 	(34)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 	(1,401) 	(1,477)
Effect of exchange rate changes on cash and cash equivalents 	(53) 	(2)
Net increase (decrease) in cash and cash equivalents 	1,866 	(4)
Cash and cash equivalents at beginning of year 	2,353 	2,853
Cash and cash equivalents at end of period 	$ 4,219 	$ 2,849
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)

-- 8 of 23 --

(Dollars in
millions, except
per share
amounts)
Operating
Income
Operating
Income
Margin
Income
Before
Taxes
Provision
for
Income
Taxes
Effective
Tax Rate
Net Income
Attributable
to 3M
Earnings
Per
Diluted
Share
Q2 2019 GAAP $ 1,702 	20.8% $ 1,446 $ 315 	21.8% $ 1,127 $ 1.92
Adjustments for
special items:
Loss on
deconsolidation
of Venezuelan
subsidiary 	— 	162 	— 	162 	0.28
(Gain)/loss on
sale of
businesses 	— 	— 	43 	(43) 	(0.07
Q2 2019 adjusted
amounts (non-
GAAP measures)
(a) 	$ 1,702 	20.8% $ 1,608 $ 358 	22.3% $ 1,246 $ 2.13
Q2 2020 GAAP $ 1,740 	24.3% $ 1,629 $ 342 	21.0% $ 1,290 $ 2.22
Adjustments for
special items:
(Gain)/loss on
sale of
businesses 	(387) 	(387) 	(83) 	(304) 	(0.52
Divestiture-
related
restructuring
actions 	55 	55 	9 	46 	0.08
Q2 2020 adjusted
amounts (non-
GAAP measures)
(a) 	$ 1,408 	19.6% $ 1,297 $ 268 	20.7% $ 1,032 $ 1.78
(Dollars in
millions, except
per share
amounts)
Operating
Income
Operating
Income
Margin
Income
Before
Taxes
Provision
for
Income
Taxes
Effective
Tax Rate
Net Income
Attributable
to 3M
Earnings
Per
Diluted
Share
First six months
2019 GAAP 	$ 2,838 	17.7% $ 2,534 $ 510 	20.1% $ 2,018 $ 3.44
Adjustments for
special items:

-- 9 of 23 --

Significant
litigation-related
charges/benefits 	548 	548 	124 	424 	0.72
Loss on
deconsolidation
of Venezuelan
subsidiary 	— 	162 	— 	162 	0.28
(Gain)/loss on
sale of
businesses 	(8) 	(8) 	42 	(50) 	(0.09
First six months
2019 adjusted
amounts (non-
GAAP measures)
(a) 	$ 3,378 	21.1% $ 3,236 $ 676 	20.9% $ 2,554 $ 4.35
First six months
2020 GAAP 	$ 3,403 	22.3% $ 3,196 $ 615 	19.2% $ 2,582 $ 4.44
Adjustments for
special items:
Significant
litigation-related
charges/benefits 	17 	17 	56 	(39) 	(0.07
(Gain)/loss on
sale of
businesses 	(389) 	(389) 	(86) 	(303) 	(0.52
Divestiture-
related
restructuring
actions 	55 	55 	9 	46 	0.08
First six months
2020 adjusted
amounts (non-
GAAP measures)
(a) 	$ 3,086 	20.2% $ 2,879 $ 594 	20.7% $ 2,286 $ 3.93

-- 10 of 23 --

(a) In addition to reporting financial results in accordance with U.S. GAAP, the Company
also provides non-GAAP measures that adjust for the special items. Special items for the
periods presented include the items described in the section entitled “Description of
Special Items”. Beginning in 2020, the Company includes gain/loss on sale of businesses
and divestiture-related restructuring actions as special items due to their potential
distortion of underlying operating results. Information provided herein reflects the impact
of this change for all periods presented. Operating income, income before taxes, net
income, earnings per share, and effective tax rate are all measures for which 3M
provides the reported GAAP measure and a measure adjusted for special items. The
adjusted measures are not in accordance with, nor are they a substitute for, GAAP
measures. The Company considers these non-GAAP measures in evaluating and
managing the Company’s operations. The Company believes that discussion of results
adjusted for these items is meaningful to investors as it provides a useful analysis of
ongoing underlying operating trends. The determination of these items may not be
comparable to similarly titled measures used by other companies.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Three months
ended 	Six months ended
June 30, 	June 30,
Major GAAP Cash Flow Categories
(dollars in millions) 	2020 	2019 	2020 	2019
Net cash provided by (used in) operating
activities 	$ 1,905 	$ 1,662 	$ 3,118 	$ 2,710
Net cash provided by (used in) investing
activities 	577 	(10) 	202 	(1,235)
Net cash provided by (used in) financing
activities 	(2,509) 	(1,735) 	(1,401) 	(1,477)
Adjusted Free Cash Flow (non-GAAP
measure) (dollars in millions)
Net cash provided by (used in) operating
activities 	$ 1,905 	$ 1,662 	$ 3,118 	$ 2,710
Purchases of property, plant and equipment 	(379) 	(421) 	(711) 	(812)
Free cash flow 	$ 1,526 	$ 1,241 	$ 2,407 	$ 1,898
Adjustments for special items:
Significant litigation-related after-tax
payment impacts 	$ 14 	$ 31 	$ 64 	$ 31
Divestiture-related restructuring after-tax
payment impacts 	— 	35 	— 	45
Adjusted free cash flow (b) 	$ 1,540 	$ 1,307 	$ 2,471 	$ 1,974

-- 11 of 23 --

Net income attributable to 3M 	$ 1,290 	$ 1,127 	$ 2,582 	$ 2,018
Adjustments for special items:
Significant litigation-related
charges/benefits 	— 	— 	(39) 	424
Loss on deconsolidation of Venezuelan
subsidiary 	— 	162 	— 	162
(Gain)/loss on sale of businesses 	(304) 	(43) 	(303) 	(50)
Divestiture-related restructuring actions 	46 	— 	46 	—
Adjusted net income attributable to 3M (a) 	$ 1,032 	$ 1,246 	$ 2,286 	$ 2,554
Adjusted free cash flow conversion (b) 	149% 	105% 	108% 	77%
(b) Adjusted free cash flow and adjusted free cash flow conversion are not defined under
U.S. GAAP. Therefore, they should not be considered a substitute for income or cash
flow data prepared in accordance with U.S. GAAP and may not be comparable to
similarly titled measures used by other companies. The Company defines adjusted free
cash flow as net cash provided by operating activities, adjusted for special items, less
purchases of property, plant and equipment. Cash payments associated with special
items in the determination of adjusted free cash flow are reflected net of applicable tax
using the U.S. statutory corporate tax rate during the period of payment. It should not be
inferred that the entire adjusted free cash flow amount is available for discretionary
expenditures. The Company defines adjusted free cash flow conversion as adjusted free
cash flow divided by net income attributable to 3M, adjusted for special items. Special
items for the periods presented include the items described in section entitled
“Description of Special Items”. The Company believes adjusted free cash flow and
adjusted free cash flow conversion are meaningful to investors as they are useful
measures of performance and the Company uses these measures as an indication of the
strength of the company and its ability to generate cash.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Adjusted EBITDA (non-
GAAP measure) (c)
Adjusted EBITDA
Margin (non-
GAAP measure)
(c)
Three months ended June
30,
Three months
ended June 30,
(Dollars in millions) 	2020 	2019 	2020 	2019
Safety and Industrial
$ 761 	$ 753 	28.5% 25.6%
Transportation and Electronics 	471 	670 	24.3 	27.3
Health Care 	439 	539 	24.1 	29.4
Consumer 	313 	297 	25.3 	22.5

-- 12 of 23 --

Corporate and Unallocated 	39 	(81)
Elimination of Dual Credit 	(123) 	(100)
Total Company 	$ 1,900 	$ 2,078 	26.5% 25.4%
Adjusted EBITDA (non-
GAAP measure) (c)
Adjusted EBITDA
Margin (non-
GAAP measure)
(c)
Six months ended June
30,
Six months
ended June 30,
(Dollars in millions) 	2020 	2019 	2020 	2019
Safety and Industrial 	$ 1,586 	$ 1,490 	28.3% 25.3%
Transportation and Electronics 	1,030 	1,266 	24.7 	26.3
Health Care 	1,023 	1,052 	26.0 	29.5
Consumer 	598 	555 	24.0 	22.0
Corporate and Unallocated 	20 	(37)
Elimination of Dual Credit 	(239) 	(197)
Total Company 	$ 4,018 	$ 4,129 	26.3% 25.8%
Three months
ended 	Six months ended
Adjusted EBITDA (non-GAAP measure)
(dollars in millions)
June 30,
2020
June 30,
2019
June 30,
2020
June 30,
2019
Net sales 	$7,176 	$8,171 	$15,251 	$16,034
Net income attributable to 3M 	1,290 	1,127 	2,582 	2,018
Add/(subtract):
Net income/(loss) attributable to
noncontrolling interest 	(3) 	4 	(1) 	6
Provision for income taxes 	342 	315 	615 	510
Other expense/(income):
Interest (Income)/expense 	128 	93 	241 	177
Pension & OPEB non-service cost
(benefit) 	(17) 	1 	(34) 	(35)
Loss on deconsolidation of Venezuelan
subsidiary 	— 	162 	— 	162
Depreciation and amortization expense 	492 	376 	932 	751
Adjustments for special items:
Significant litigation-related
charges/benefits 	— 	— 	17 	548
(Gain)/loss on sale of businesses 	(387) 	— 	(389) 	(8)
Divestiture-related restructuring actions 	55 	— 	55 	—

-- 13 of 23 --

Adjusted EBITDA (c) 	$1,900 	$2,078 	$ 4,018 	$ 4,129
Adjusted EBITDA margin (c) 	26.5% 	25.4% 	26.3% 	25.8%
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Adjusted EBITDA
(non-GAAP
measure) Three
months ended
June 30, 2020
(dollars in millions)
Safety
and
Industrial
Transportation
and
Electronics
Health
Care Consumer
Corporate
and
Unallocated
Elimination
of Dual
Credit
Net sales 	$ 2,668 	$ 	1,937 	$1,825 $ 1,238 	$ 	(2) $ 	(490
Business segment
operating income
(measure of
segment operating
performance) 	636 	382 	306 	287 	252 	(123
Add/(subtract):
Depreciation and
amortization 	125 	89 	133 	26 	119
Adjustments for
special items:
(Gain)/loss on
sale of
businesses 	(387)
Divestiture-
related
restructuring
actions 	55
Adjusted EBITDA
(non-GAAP
measure) (c) 	$ 761 	$ 	471 	$ 439 $ 313 	$ 	39 $ 	(123
Adjusted EBITDA
margin (non-GAAP
measure) (c) 	28.5% 	24.3% 	24.1% 	25.3%

-- 14 of 23 --

Adjusted EBITDA
(non-GAAP
measure) Three
months ended
June 30, 2019
(dollars in millions)
Safety
and
Industrial
Transportation
and
Electronics Health
Care Consumer
Corporate
and
Unallocated
Elimination
of Dual
Credit
Net sales 	$ 2,937 	$ 	2,450 	$1,831 $ 1,320 	$ 	48 $ 	(415
Business segment
operating income
(measure of
segment operating
performance) 	647 	591 	483 	273 	(192) 	(100
Add/(subtract):
Depreciation and
amortization 	106 	79 	56 	24 	111
Adjusted EBITDA
(non-GAAP
measure) (c) 	$ 753 	$ 	670 	$ 539 $ 297 	$ 	(81) $ 	(100
Adjusted EBITDA
margin (non-GAAP
measure) (c) 	25.6% 	27.3% 	29.4% 	22.5%
Adjusted EBITDA
(non-GAAP
measure) Six
months ended
June 30, 2020
(dollars in millions)
Safety
and
Industrial
Transportation
and
Electronics
Health
Care Consumer
Corporate
and
Unallocated
Elimination
of Dual
Credit
Net sales 	$ 5,603 	$ 	4,175 	$3,928 $ 2,494 	$ 	(1) $ 	(948
Business segment
operating income
(measure of
segment operating
performance) 	1,362 	864 	762 	556 	98 	(239
Add/(subtract):
Depreciation and
amortization 	224 	166 	261 	42 	239
Adjustments for
special items:

-- 15 of 23 --

Significant
litigation-related
charges/benefits 	17
(Gain)/loss on
sale of
businesses 	(389)
Divestiture-
related
restructuring
actions 55
Adjusted EBITDA
(non-GAAP
measure) (c) 	$ 1,586 	$ 	1,030 	$1,023 $ 598 	$ 	20 $ 	(239
Adjusted EBITDA
margin (non-GAAP
measure) (c) 	28.3% 	24.7% 	26.0% 	24.0%
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Adjusted EBITDA
(non-GAAP
measure) Six
months ended
June 30, 2019
(dollars in millions)
Safety
and
Industrial
Transportation
and
Electronics
Health
Care Consumer
Corporate
and
Unallocated
Elimination
of Dual
Credit
Net sales 	$ 5,900 $ 	4,805 	$3,569 $ 2,520 	$ 	70 $ 	(830
Business segment
operating income
(measure of
segment operating
performance) 	1,284 	1,110 	942 	508 	(809) 	(197
Add/(subtract):
Depreciation and
amortization 	206 	156 	110 	47 	232
Adjustments for
special items:
Significant
litigation-related
charges/benefits 	548

-- 16 of 23 --

(Gain)/loss on
sale of
businesses (8)
Adjusted EBITDA
(non-GAAP
measure) (c) 	$ 1,490 $ 	1,266 	$1,052 $ 555 	$ 	(37) $ 	(197
Adjusted EBITDA
margin (non-GAAP
measure) (c) 	25.3% 	26.3% 	29.5% 	22.0%
(c) Adjusted EBITDA and adjusted EBITDA margin are not defined under U.S. GAAP.
Therefore, adjusted EBITDA and adjusted EBITDA margin should not be considered a
substitute for other measures prepared in accordance with U.S. GAAP and may not be
comparable to similarly titled measures used by other companies. The Company defines
adjusted EBITDA as net income attributable to 3M, adjusted for net income/(loss)
attributable to noncontrolling interest, provision for income taxes, other
expense/(income), depreciation and amortization expense, and special items. For
business segments, the Company defines adjusted EBITDA as business segment
operating income (3M’s measure of segment operating performance) adjusted for
depreciation and amortization expense. The Company defines adjusted EBITDA margin
as adjusted EBITDA divided by net sales. Special items for the periods presented include
the items described in the section entitled “Description of Special Items”. The Company
considers these non-GAAP measures in evaluating and managing the Company’s
operations. The Company believes adjusted EBITDA and adjusted EBITDA margin are
meaningful to investors as they provide useful analyses of ongoing underlying operating
trends.
June 30,
December
31,
Net Debt (non-GAAP measure) 	2020 	2019
Total debt 	$ 20,762 	$ 20,313
Less: Cash, cash equivalents and marketable securities 	4,500 	2,494
Net debt (d) 	$ 16,262 	$ 17,819
(d) Net debt is not defined under U.S. GAAP and may not be computed the same as
similarly titled measures used by other companies. The Company defines net debt as
total debt less the total of cash, cash equivalents and current and long-term marketable
securities. 3M believes net debt is meaningful to investors as 3M considers net debt and
its components to be an important indicator of liquidity and a guiding measure of capital
structure strategy.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION

-- 17 of 23 --

NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
Description of Special Items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also
provides various non-GAAP measures that incorporate adjustments for the impacts of
special items. Special items incorporated in the preparation of these non-GAAP measures
for the periods presented include the items described below:
Significant litigation-related charges/benefits:
In the first quarter of 2020, 3M recorded a net pre-tax charge of $17 million ($13 million
after tax) related to PFAS (certain perfluorinated compounds) matters. The charge was
more than offset by a reduction in tax expense of $52 million related to resolution of tax
treatment with authorities regarding the previously disclosed 2018 agreement reached
with the State of Minnesota that resolved the Natural Resources Damages (NRD)
lawsuit. These items, in aggregate, resulted in a $39 million after-tax benefit. In the
second quarter and first six months of 2020, 3M made payments of approximately $18
million and $81 million, respectively, related to significant litigation-related matters.
In the first quarter of 2019, 3M recorded significant litigation-related charges of $548
million ($424 million after tax) related to historical PFAS manufacturing operations and
coal mine dust respirator mask lawsuits. In the second quarter of 2019, 3M made
payments of approximately $39 million related to significant litigation-related matters.
Loss on deconsolidation of Venezuelan subsidiary:
In the second quarter of 2019, 3M recorded a pre-tax charge of $162 million related to
the deconsolidation of the Company’s Venezuelan subsidiary.
Gain/loss on sale of businesses:
In the first quarter of 2020, 3M recorded a pre-tax gain of $2 million ($1 million loss
after tax) related to the sale of its advanced ballistic-protection business and
recognition of certain contingent consideration. In the second quarter of 2020, 3M
recorded a pre-tax gain of $387 million ($304 million after tax) related to the sale of its
drug delivery business.
In the first quarter of 2019, 3M recorded a gain related to the sale of certain oral care
technology comprising a business in addition to reflecting an earnout on a previous
divestiture, which together resulted in a net gain of $8 million ($7 million after tax). In
the second quarter of 2019, as a result of a “held for sale” tax benefit related to the
legal entities associated with the pending divestiture of the Company’s gas and flame
detection business, 3M recorded an after-tax gain of $43 million.
Divestiture-related restructuring actions:
In the second quarter of 2020, following the divestiture of substantially all of the drug
delivery business, management approved and committed to undertake certain
restructuring actions addressing corporate functional costs and manufacturing footprint
across 3M in relation to the magnitude of amounts previously allocated/burdened to

-- 18 of 23 --

the divested business. As a result, 3M recorded a pre-tax charge of $55 million ($46
million after tax).
In the second quarter and first six months of 2019, 3M made payments of
approximately $44 million and $57 million, respectively, associated with restructuring
charges taken in 2018 related to addressing corporate functional costs following the
2018 Communication Markets Division divestiture.
3M Company and Subsidiaries
SALES CHANGE ANALYSIS (e)
(Unaudited)
Three months ended June 30, 2020
Europe,
Middle
Sales Change
Analysis 	Asia- 	East and 	World-
By Geographic
Area 	Americas 	Pacific 	Africa 	Wide
Volume – organic 	(16.6)% 	(7.8)% 	(15.2)% 	(13.6)%
Price 	1.0 	(0.3) 	0.7 	0.5
Organic local-
currency sales 	(15.6) 	(8.1) 	(14.5) 	(13.1)
Acquisitions 	5.9 	0.9 	3.2 	3.9
Divestitures 	(1.6) 	(0.1) 	(3.0) 	(1.5)
Translation 	(1.4) 	(1.2) 	(2.1) 	(1.5)
Total sales change 	(12.7)% 	(8.5)% 	(16.4)% 	(12.2)%
Three months ended June 30, 2020
Worldwide Sales
Change 	Organic local- 	Total sales
By Business
Segment 	currency sales Acquisitions Divestitures Translation change
Safety and
Industrial 	(6.1)% 	—% 	(0.9)% 	(2.2)% 	(9.2)%
Transportation and
Electronics 	(18.9) 	— 	(1.1) 	(0.9) 	(20.9)
Health Care 	(12.4) 	17.9 	(4.3) 	(1.6) 	(0.4)
Consumer 	(5.0) 	— 	— 	(1.2) 	(6.2)
Total Company (13.1)% 	3.9% 	(1.5)% 	(1.5)% 	(12.2)%
Six months ended June 30, 2020
Europe,
Middle

-- 19 of 23 --

Sales Change Analysis Asia- 	East and 	World-
By Geographic Area 	Americas 	Pacific 	Africa 	Wide
Volume – organic 	(7.1)% 	(5.8)% 	(8.9)% 	(7.0)%
Price 	0.9 	(0.4) 	0.9 	0.5
Organic local-currency
sales 	(6.2) 	(6.2) 	(8.0) 	(6.5)
Acquisitions 	6.9 	0.9 	3.4 	4.4
Divestitures 	(1.3) 	(0.1) 	(2.2) 	(1.2)
Translation 	(1.3) 	(1.5) 	(2.4) 	(1.6)
Total sales change 	(1.9)% 	(6.9)% 	(9.2)% 	(4.9)%
Six months ended June 30, 2020
Worldwide Sales
Change
Organic
local-
Total
sales
By Business Segment
currency
sales 	Acquisitions Divestitures Translation change
Safety and Industrial 	(1.9)% 	—% 	(0.9)% 	(2.2)% 	(5.0)%
Transportation and
Electronics 	(11.1) 	— 	(0.9) 	(1.1) 	(13.1)
Health Care 	(5.6) 	19.7 	(2.3) 	(1.7) 	10.1
Consumer 	0.3 	— 	— 	(1.3) 	(1.0)
Total Company 	(6.5)% 	4.4% 	(1.2)% 	(1.6)% 	(4.9)%
(e) Total sales change is calculated based on reported sales results. The components of
sales change include organic local-currency sales, acquisitions, divestitures and
translation. Organic local-currency sales includes both organic volume impacts (which
excludes acquisition and divestiture impacts) and selling price changes. Acquisition and
divestiture impacts are measured separately for the first 12 months post-transaction.
3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)
Effective in the second quarter of 2020, the measure of segment operating performance
used by 3M’s chief operating decision maker (CODM) changed and, as a result, 3M’s
disclosed measure of segment profit/loss (business segment operating income) has been
updated for all periods presented. The change to business segment operating income aligns
with the update to how the CODM assesses performance and allocates resources for the
Company’s business segments.
3M discloses business segment operating income as its measure of segment profit/loss,
reconciled to both total 3M operating income and income before taxes. Business segment
operating income includes dual credit for certain related operating income (as described
below in “Elimination of Dual Credit”). Business segment operating income excludes certain
expenses and income that are not allocated to business segments (as described below in

-- 20 of 23 --

“Corporate and Unallocated”). Additionally, the following special items are excluded from
business segment operating income and, instead, are included within Corporate and
Unallocated: significant litigation-related charges/benefits, gain/loss on sale of businesses,
and divestiture-related restructuring actions.
In addition, effective in the first quarter of 2020, in a continuing effort to improve the
alignment of its businesses around customers and markets, the Company made the
following changes:
Continued alignment of customer account activity
As part of 3M’s regular customer-focus initiatives, the Company realigned certain
customer account activity (“sales district”) to correlate with the primary divisional
product offerings in various countries and reduce complexity for customers when
interacting with multiple 3M businesses. This largely impacted the amount of dual
credit certain business segments receive as a result of sales district attribution. 3M
business segment reporting measures include dual credit to business segments for
certain sales and operating income. This dual credit is based on which business
segment provides customer account activity with respect to a particular product sold in
a specific country.
Additional actions impacting product line alignments
The remaining retail auto care product lines formerly in the Automotive Aftermarket
Division (within the Safety and Industrial business segment) were realigned to the
Construction and Home Improvement Division (within the Consumer business
segment).
In addition, certain product lines were realigned within business segments. The
transdermal drug delivery components business, formerly included in the Drug Delivery
Systems Division, was realigned to the Medical Solutions Division (both of which are
within the Health Care business segment) and the paint protection film business,
formerly included in the Automotive and Aerospace Division, was realigned to the
Commercial Solutions Division (both of which are within the Transportation and
Electronics business segment).
The financial information presented herein reflects the impact of these changes for all
periods presented.
BUSINESS SEGMENT INFORMATION
Three months
ended 	Six months ended
NET SALES 	June 30, 	June 30,
(Millions) 	2020 	2019 	2020 	2019
Safety and Industrial 	$ 2,668 $ 2,937 $ 5,603 $ 5,900
Transportation and Electronics 	1,937 	2,450 	4,175 	4,805
Health Care 	1,825 	1,831 	3,928 	3,569
Consumer 	1,238 	1,320 	2,494 	2,520
Corporate and Unallocated 	(2) 	48 	(1) 	70

-- 21 of 23 --

Elimination of Dual Credit 	(490) 	(415) 	(948) 	(830)
Total Company 	$ 7,176 $ 8,171 $ 15,251 $ 16,034
3M Company and Subsidiaries
BUSINESS SEGMENTS – (CONTINUED)
(Unaudited)
BUSINESS SEGMENT INFORMATION
Three months
ended 	Six months ended
OPERATING INCOME 	June 30, 	June 30,
(Millions) 	2020 	2019 	2020 	2019
Safety and Industrial 	$ 636 $ 647 $ 1,362 $ 1,284
Transportation and Electronics 	382 	591 	864 	1,110
Health Care 	306 	483 	762 	942
Consumer 	287 	273 	556 	508
Elimination of Dual Credit 	(123) 	(100) 	(239) 	(197)
Total business segment operating income $ 1,488 $ 1,894 $ 3,305 $ 3,647
Corporate and Unallocated
Special items:
Significant litigation-related
(charges)/benefits 	— 	— 	(17) 	(548)
Gain/(loss) on sale of businesses 	387 	— 	389 	8
Divestiture-related restructuring actions 	(55) 	— 	(55) 	—
Other corporate expense - net 	(80) 	(192) 	(219) 	(269)
Total Corporate and Unallocated 	$ 252 $ (192) $ 98 $ (809)
Total Company operating income 	$ 1,740 $ 1,702 $ 3,403 $ 2,838
Other expense/(income), net 	$ 111 $ 256 $ 207 $ 304
Income before income taxes $ 1,629 $ 1,446 $ 3,196 $ 2,534
About 3M
At 3M, we apply science in collaborative ways to improve lives daily. With $32 billion in
sales, our 96,000 employees connect with customers all around the world. Learn more about
3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or
@3MNews.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20200728005486/en/
3M
Investor Contacts:
Bruce Jermeland, 651-733-1807
or
Tony Riter, 651-733-1141
or

-- 22 of 23 --

Media Contact:
Fanna Haile-Selassie, 651-736-0876
Source: 3M

-- 23 of 23 --